
The Biden administration announced plans on April 26, 2022, to increase the availability of the COVID-19 drug Paxlovid, vowing to get more of the treatment pills into the hands of Americans.
An oral antiviral, Paxlovid has proved successful at reducing the chances of hospitalization among COVID-19 sufferers, but has suffered from a slow rollout to pharmacies across the U.S.